Charles River Associates delivered a robust third quarter, with the market reacting positively as revenue and profitability exceeded Wall Street expectations. Management credited the outperformance to strong demand across its core practices—especially Forensic Services, Life Sciences, and Antitrust & Competition Economics—which each posted double-digit growth. CEO Paul Maleh highlighted sustained client demand, noting, “Seven practices grew year-over-year, representing approximately 95% of the company’s total revenue for the third quarter.” The company’s ability to integrate new consultants rapidly and maintain high utilization rates further contributed to margin expansion, with operational execution enabling record profitability despite seasonal workforce transitions.

Is now the time to buy CRAI? Find out in our full research report (it’s free for active Edge members).

While we enjoy listening to the management’s commentary, our favorite part of earnings calls is the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our top 5 analyst questions from CRA’s Q3 earnings call

• Andrew Nicholas (William Blair): asked if headcount growth could trend to high single digits. CEO Paul Maleh confirmed mid-single digit growth is likely, citing integration speed and strong demand, but cautioned against expecting higher levels.
• Nicholas (William Blair): inquired about AI’s impact on litigation demand. Maleh clarified that while AI tools are used in delivery, direct client demand for AI-related needs is not yet a major driver.
• Marc Riddick (Sidoti & Company): questioned what is fueling outperformance in legal and regulatory services. Maleh attributed it to new consultant contributions and organic client growth across geographies.
• Riddick (Sidoti & Company): asked about the shift in growth trends between North America and Europe. Maleh explained North America’s outperformance was driven by staffing and business opportunities, but expects international operations to remain strong.
• Kevin Steinke (Barrington Research): probed whether higher utilization rates are sustainable. Maleh credited rapid onboarding and robust demand, stating the company will be measured in further headcount expansion.

Catalysts in upcoming quarters

Going forward, the StockStory team will be watching (1) whether CRA can maintain elevated utilization rates as new consultants are added, (2) if the Forensic Services and Antitrust & Competition Economics practices continue to deliver above-market growth despite industry fluctuations, and (3) management’s success in mitigating rising non-cash expenses and managing exposure to regulatory tax changes. The evolution of client demand for AI-related advisory and cybersecurity services will also be an important indicator of long-term growth.

CRA currently trades at $196.50, in line with $194.75 just before the earnings. Is there an opportunity in the stock? Find out in our full research report (it’s free).

The best stocks for high-quality investors

ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.

Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.